Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Gilead Sciences Inc. (GILD)

64.33   -0.59 (-0.91%) 03-22 14:33
Open: 64.86 Pre. Close: 64.92
High: 65.09 Low: 64.05
Volume: 3,507,177 Market Cap: 82054M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 65.08 - 65.396 65.396 - 65.668
Low: 62.252 - 62.613 62.613 - 62.924
Close: 64.37 - 64.939 64.939 - 65.431

Technical analysis

as of: 2019-03-22 1:57:22 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 76.56     One year: 79.16
Support: Support1: 61.96    Support2: 51.55
Resistance: Resistance1: 65.55    Resistance2: 67.77
Pivot: 64.54
Moving Average: MA(5): 64.84     MA(20): 64.76
MA(100): 67.23     MA(250): 70.86
MACD: MACD(12,26): -0.46     Signal(9): -0.56
Stochastic oscillator: %K(14,3): 57.61     %D(3): 64.44
RSI: RSI(14): 43.85
52-week: High: 79.61  Low: 60.32  Change(%): -11.9
Average Vol(K): 3-Month: 760740  10-Days: 722644

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GILD has closed above bottom band by 40.0%. Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to GILD's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 21 Mar 2019 16:10:55 Z
Does Recent AbbVie Stock Weakness Make It A Buy? 3 Pros, 3 Cons

Wed, 20 Mar 2019 00:09:33 Z
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know

Mon, 18 Mar 2019 20:56:39 Z
After Hours Most Active for Mar 18, 2019 : ELAN, LLY, BAC, MRK, HPQ, WMB, QCOM, GILD, CMCSA, PEP, EBAY, ATVI

Mon, 18 Mar 2019 17:12:56 Z
YETI, Gilead, Dick's, FedEx and Amazon highlighted as Zacks Bull and Bear of the Day

Mon, 18 Mar 2019 13:12:43 Z
Bear of the Day: Gilead Sciences (GILD)

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 1275.51
Shares Float (M) 1268.03
% Held by Insiders 0.60
% Held by Institutions 127.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 6.160
EPS Est. Current Year 8.790
EPS Est. Next Year 7.340
EPS Est. Next Quarter 1.900
Forward EPS 6.477
Book Value (p.s.) 3.860
PEG Ratio -2.71
Profit Margin 24.68
Operating Margin 40.76
Return on Assets (ttm) 8.1
Return on Equity (ttm) 26.1
Qtrly Rev. Growth -2.6
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 8400.00
Levered Free Cash Flow (M) 6470.00

Stock Valuations

P/E 10.41
P/E Growth Ratio -0.01
P/BV 16.62
P/S 4816328192.00
P/CF 9.74

Dividends & Splits

Dividend 3.840
Dividend Yield 0.06
Dividend Pay Date 2019-03-28
Ex-Dividend Date 2019-03-14
Forward Dividend 2.520
Last Split Date 2013-01-28
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.